(+)-catechin multiple interactions ISO RGD:732269 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of GRIN2A mRNA CTD PMID:24763279 (+)-pilocarpine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Pilocarpine results in increased expression of GRIN2A protein] more ... CTD PMID:16600505 , PMID:22824136 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GRIN2A protein CTD PMID:22824136 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of GRIN2A protein CTD PMID:15857427 (25R)-cholest-5-ene-3beta,26-diol decreases phosphorylation EXP 6480464 27-hydroxycholesterol results in decreased phosphorylation of GRIN2A protein CTD PMID:18503570 (R)-lipoic acid multiple interactions EXP 6480464 [Thioctic Acid co-treated with Propylthiouracil] results in increased expression of GRIN2A mRNA CTD PMID:31068541 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GRIN2A mRNA CTD PMID:20068009 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10686 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20297801 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10686 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:10686 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GRIN2A mRNA CTD PMID:11742229 , PMID:16839606 26-hydroxycholesterol decreases phosphorylation EXP 6480464 27-hydroxycholesterol results in decreased phosphorylation of GRIN2A protein CTD PMID:18503570 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10686 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GRIN2A mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane increases expression ISO RGD:10686 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GRIN2A mRNA CTD PMID:18648102 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol multiple interactions EXP 6480464 ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIN2A protein], ifenprodil inhibits the reaction [Pilocarpine results in increased expression of GRIN2A protein] CTD PMID:19474322 , PMID:22824136 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GRIN2A mRNA CTD PMID:24780913 6-propyl-2-thiouracil multiple interactions EXP 6480464 [Thioctic Acid co-treated with Propylthiouracil] results in increased expression of GRIN2A mRNA CTD PMID:31068541 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of GRIN2A mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:732269 6480464 Aflatoxin B1 results in increased methylation of GRIN2A gene CTD PMID:28458013 aflatoxin B2 increases methylation ISO RGD:732269 6480464 aflatoxin B2 results in increased methylation of GRIN2A intron CTD PMID:30157460 allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [ammonium acetate results in decreased expression of GRIN2A protein] CTD PMID:20084674 Amaranth multiple interactions EXP 6480464 [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein, [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 ammonium acetate multiple interactions EXP 6480464 Allopurinol inhibits the reaction [ammonium acetate results in decreased expression of GRIN2A protein] CTD PMID:20084674 ammonium acetate decreases expression EXP 6480464 ammonium acetate results in decreased expression of GRIN2A protein CTD PMID:20084674 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GRIN2A mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of GRIN2A protein CTD PMID:16483693 ammonium chloride affects localization EXP 6480464 Ammonium Chloride affects the localization of GRIN2A protein CTD PMID:16678351 antirheumatic drug increases expression ISO RGD:732269 6480464 Antirheumatic Agents results in increased expression of GRIN2A mRNA CTD PMID:24449571 arsenite(3-) decreases expression ISO RGD:10686 6480464 arsenite results in decreased expression of GRIN2A mRNA, arsenite results in decreased expression of GRIN2A protein CTD PMID:31708534 benzo[a]pyrene multiple interactions ISO RGD:10686 6480464 POR protein affects the reaction [Benzo(a)pyrene results in increased expression of GRIN2A protein] CTD PMID:21987461 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GRIN2A mRNA CTD PMID:17606297 benzo[a]pyrene affects expression ISO RGD:10686 6480464 Benzo(a)pyrene affects the expression of GRIN2A mRNA CTD PMID:23684556 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of GRIN2A mRNA CTD PMID:21839799 , PMID:22108330 benzo[a]pyrene increases expression ISO RGD:10686 6480464 Benzo(a)pyrene results in increased expression of GRIN2A mRNA, Benzo(a)pyrene results in increased expression of GRIN2A protein CTD PMID:21987461 , PMID:27195522 benzo[e]pyrene increases methylation ISO RGD:732269 6480464 benzo(e)pyrene results in increased methylation of GRIN2A intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of GRIN2A mRNA CTD PMID:28871463 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732269 6480464 Diethylhexyl Phthalate results in decreased expression of GRIN2A mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:10686 6480464 Ashwagandha inhibits the reaction [bisphenol A results in decreased expression of GRIN2A protein], diphenyldiselenide inhibits the reaction [bisphenol A results in decreased expression of GRIN2A protein] CTD PMID:28572023 , PMID:31064381 bisphenol A decreases expression ISO RGD:732269 6480464 bisphenol A results in decreased expression of GRIN2A mRNA CTD PMID:31715268 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GRIN2A gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GRIN2A mRNA, bisphenol A results in decreased expression of GRIN2A protein CTD PMID:20821433 , PMID:30816183 bisphenol A decreases expression ISO RGD:10686 6480464 bisphenol A results in decreased expression of GRIN2A protein CTD PMID:20206181 more ... Brilliant Blue multiple interactions EXP 6480464 [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein, [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 celecoxib multiple interactions ISO RGD:10686 6480464 Celecoxib promotes the reaction [Kainic Acid results in decreased expression of GRIN2A mRNA] CTD PMID:21589914 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GRIN2A mRNA CTD PMID:17452286 , PMID:19440498 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GRIN2A mRNA CTD PMID:18668222 choline multiple interactions EXP 6480464 Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2A mRNA] CTD PMID:20381573 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of GRIN2A mRNA CTD PMID:12608697 , PMID:18923069 cocaine multiple interactions ISO RGD:10686 6480464 HDAC5 affects the reaction [Cocaine affects the expression of GRIN2A mRNA] CTD PMID:17988634 cocaine multiple interactions EXP 6480464 ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIN2A protein] CTD PMID:19474322 cocaine increases expression EXP 6480464 Cocaine results in increased expression of GRIN2A mRNA, Cocaine results in increased expression of GRIN2A protein CTD PMID:17898221 more ... cocaine affects expression EXP 6480464 Cocaine affects the expression of GRIN2A mRNA, Cocaine affects the expression of GRIN2A protein CTD PMID:19105975 , PMID:20187946 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of GRIN2A mRNA], Curcumin inhibits the reaction [sodium arsenite results in decreased expression of GRIN2A protein] CTD PMID:29723552 dextromethorphan increases expression EXP 6480464 Dextromethorphan results in increased expression of GRIN2A protein CTD PMID:28916251 Diacetoxyscirpenol decreases expression ISO RGD:10686 6480464 diacetoxyscirpenol results in decreased expression of GRIN2A mRNA CTD PMID:31836554 diazepam affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Diazepam CTD PMID:15731593 diazinon affects expression EXP 6480464 Diazinon affects the expression of GRIN2A mRNA CTD PMID:19440498 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GRIN2A mRNA CTD PMID:17452286 dinitrogen oxide multiple interactions ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] CTD PMID:15731593 dorsomorphin multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732269 6480464 Doxorubicin results in decreased expression of GRIN2A mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:732269 6480464 entinostat results in increased expression of GRIN2A mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRIN2A mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of GRIN2A mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:10686 6480464 Ethanol results in increased expression of GRIN2A mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:732269 6480464 Ethyl Methanesulfonate results in decreased expression of GRIN2A mRNA CTD PMID:23649840 excitatory amino acid agonist multiple interactions ISO RGD:732269 6480464 [GRIN1 protein co-treated with GRIN2A protein] results in increased susceptibility to Excitatory Amino Acid Agonists more ... CTD PMID:11812690 , PMID:19224577 excitatory amino acid agonist decreases expression ISO RGD:732269 6480464 Excitatory Amino Acid Agonists results in decreased expression of GRIN2A mRNA CTD PMID:28987794 felbamate multiple interactions EXP 6480464 felbamate results in decreased activity of [GRIN1 protein alternative form binds to GRIN2A protein] CTD PMID:10690753 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of GRIN2A protein CTD PMID:20417256 folic acid increases expression EXP 6480464 Folic Acid deficiency results in increased expression of GRIN2A protein CTD PMID:20406136 folic acid multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Folic Acid deficiency results in increased expression of GRIN2A protein] CTD PMID:20406136 formaldehyde increases expression ISO RGD:10686 6480464 Formaldehyde results in increased expression of GRIN2A mRNA CTD PMID:17434604 formaldehyde multiple interactions ISO RGD:10686 6480464 Dizocilpine Maleate inhibits the reaction [Formaldehyde results in increased expression of GRIN2A mRNA] CTD PMID:17434604 furan increases methylation EXP 6480464 furan results in increased methylation of GRIN2A gene CTD PMID:22079235 genistein decreases expression EXP 6480464 Genistein results in decreased expression of GRIN2A mRNA CTD PMID:21782745 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of GRIN2A mRNA, Haloperidol results in decreased expression of GRIN2A protein CTD PMID:12608697 more ... hydrogen peroxide affects expression ISO RGD:732269 6480464 Hydrogen Peroxide affects the expression of GRIN2A protein CTD PMID:21179406 indigo carmine multiple interactions EXP 6480464 [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein, [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 kainic acid decreases expression ISO RGD:10686 6480464 Kainic Acid results in decreased expression of GRIN2A mRNA CTD PMID:21589914 kainic acid multiple interactions ISO RGD:10686 6480464 celecoxib promotes the reaction [Kainic Acid results in decreased expression of GRIN2A mRNA] CTD PMID:21589914 ketamine affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Ketamine CTD PMID:15731593 ketamine increases expression EXP 6480464 Ketamine results in increased expression of GRIN2A mRNA CTD PMID:20080153 lead diacetate multiple interactions EXP 6480464 Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2A mRNA] CTD PMID:20381573 lead diacetate increases expression ISO RGD:10686 6480464 lead acetate results in increased expression of GRIN2A mRNA CTD PMID:24260418 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of GRIN2A mRNA CTD PMID:22362014 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GRIN2A mRNA, lead acetate results in decreased expression of GRIN2A protein CTD PMID:20381573 , PMID:22160880 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GRIN2A mRNA CTD PMID:15973774 lead nitrate multiple interactions ISO RGD:10686 6480464 lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA], lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA] CTD PMID:11891201 leflunomide increases expression ISO RGD:732269 6480464 leflunomide results in increased expression of GRIN2A mRNA CTD PMID:28988120 lipoic acid multiple interactions EXP 6480464 [Thioctic Acid co-treated with Propylthiouracil] results in increased expression of GRIN2A mRNA CTD PMID:31068541 lipoteichoic acid multiple interactions ISO RGD:10686 6480464 [Particulate Matter co-treated with lipoteichoic acid] results in increased expression of GRIN2A mRNA, [Vehicle Emissions co-treated with lipoteichoic acid] results in increased expression of GRIN2A mRNA CTD PMID:18926851 , PMID:19653804 lithium atom multiple interactions EXP 6480464 [Lithium co-treated with Pilocarpine] results in increased phosphorylation of GRIN2A protein CTD PMID:16600505 lithium hydride multiple interactions EXP 6480464 [Lithium co-treated with Pilocarpine] results in increased phosphorylation of GRIN2A protein CTD PMID:16600505 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of GRIN2A mRNA, Manganese results in decreased expression of GRIN2A protein CTD PMID:19643132 , PMID:29205667 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of GRIN2A mRNA, Manganese results in decreased expression of GRIN2A protein CTD PMID:19643132 , PMID:29205667 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of GRIN2A mRNA, manganese chloride results in decreased expression of GRIN2A protein CTD PMID:20175136 mercury dibromide decreases expression ISO RGD:732269 6480464 mercuric bromide results in decreased expression of GRIN2A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GRIN2A mRNA CTD PMID:18419818 methapyrilene increases methylation ISO RGD:732269 6480464 Methapyrilene results in increased methylation of GRIN2A intron CTD PMID:30157460 methotrexate increases expression ISO RGD:732269 6480464 Methotrexate results in increased expression of GRIN2A mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:732269 6480464 Methyl Methanesulfonate results in decreased expression of GRIN2A mRNA CTD PMID:23649840 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of GRIN2A mRNA, methylmercuric chloride results in decreased expression of GRIN2A protein CTD PMID:19409459 , PMID:22223486 methylmercury chloride multiple interactions EXP 6480464 Polyphenols inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A mRNA], Polyphenols inhibits the reaction [methylmercuric chloride results in decreased expression of GRIN2A protein] CTD PMID:22223486 midazolam affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Midazolam CTD PMID:15731593 minocycline multiple interactions EXP 6480464 Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2A mRNA] CTD PMID:19660546 morphine increases expression ISO RGD:10686 6480464 Morphine results in increased expression of GRIN2A protein CTD PMID:12878694 morphine affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Morphine CTD PMID:12878694 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of GRIN2A mRNA CTD PMID:28688903 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of GRIN2A mRNA CTD PMID:28688903 nickel atom decreases expression ISO RGD:732269 6480464 Nickel results in decreased expression of GRIN2A mRNA CTD PMID:24768652 , PMID:25583101 nobiletin increases expression EXP 6480464 nobiletin results in increased expression of GRIN2A mRNA CTD PMID:24964900 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of GRIN2A mRNA CTD PMID:27346841 oxybenzone affects expression EXP 6480464 oxybenzone affects the expression of GRIN2A protein CTD PMID:31368502 ozone multiple interactions ISO RGD:10686 6480464 [[Ozone results in increased oxidation of Particulate Matter] which results in increased chemical synthesis of Aerosols] which results in decreased expression of GRIN2A mRNA, [[Ozone results in increased oxidation of Vehicle Emissions] which results in increased chemical synthesis of Aerosols] which results in decreased expression of GRIN2A mRNA CTD PMID:25361045 p-chloromercuribenzoic acid decreases expression ISO RGD:732269 6480464 p-Chloromercuribenzoic Acid results in decreased expression of GRIN2A mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA CTD PMID:27188386 paraquat increases expression ISO RGD:10686 6480464 Paraquat results in increased expression of GRIN2A mRNA CTD PMID:22563483 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GRIN2A mRNA CTD PMID:18198484 pentobarbital affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Pentobarbital CTD PMID:15731593 pentobarbital affects expression EXP 6480464 Pentobarbital affects the expression of GRIN2A mRNA CTD PMID:9814547 phencyclidine decreases expression ISO RGD:10686 6480464 Phencyclidine results in decreased expression of GRIN2A mRNA, Phencyclidine results in decreased expression of GRIN2A protein CTD PMID:20659557 phenylmercury acetate decreases expression ISO RGD:732269 6480464 Phenylmercuric Acetate results in decreased expression of GRIN2A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:10686 6480464 pirinixic acid results in increased expression of GRIN2A mRNA CTD PMID:20813756 poly(cytidylic acid) multiple interactions EXP 6480464 Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2A mRNA] CTD PMID:19660546 poly(cytidylic acid) increases expression EXP 6480464 Poly C results in increased expression of GRIN2A mRNA CTD PMID:19660546 profenofos decreases expression EXP 6480464 profenofos results in decreased expression of GRIN2A mRNA CTD PMID:17569032 propofol affects response to substance ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to Propofol CTD PMID:15731593 prostaglandin E2 increases response to substance ISO RGD:10686 6480464 GRIN2A results in increased susceptibility to Dinoprostone CTD PMID:9113374 SB 431542 multiple interactions ISO RGD:732269 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane multiple interactions ISO RGD:10686 6480464 GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] CTD PMID:15731593 silver atom increases expression ISO RGD:732269 6480464 Silver results in increased expression of GRIN2A mRNA CTD PMID:26551752 silver atom decreases expression ISO RGD:732269 6480464 Silver results in decreased expression of GRIN2A protein CTD PMID:27593553 silver(0) increases expression ISO RGD:732269 6480464 Silver results in increased expression of GRIN2A mRNA CTD PMID:26551752 silver(0) decreases expression ISO RGD:732269 6480464 Silver results in decreased expression of GRIN2A protein CTD PMID:27593553 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GRIN2A mRNA, sodium arsenite results in decreased expression of GRIN2A protein CTD PMID:19041379 more ... sodium arsenite multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of GRIN2A mRNA], Curcumin inhibits the reaction [sodium arsenite results in decreased expression of GRIN2A protein] CTD PMID:29723552 sodium arsenite decreases expression ISO RGD:10686 6480464 sodium arsenite results in decreased expression of GRIN2A more ... CTD PMID:29204679 , PMID:31712840 sodium arsenite affects methylation ISO RGD:732269 6480464 sodium arsenite affects the methylation of GRIN2A gene CTD PMID:28589171 sulfur dioxide decreases expression EXP 6480464 Sulfur Dioxide results in decreased expression of GRIN2A mRNA CTD PMID:25534910 Sunset Yellow FCF multiple interactions EXP 6480464 [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein, [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 T-2 Toxin increases expression ISO RGD:10686 6480464 T-2 Toxin results in increased expression of GRIN2A mRNA CTD PMID:26314264 tadalafil multiple interactions ISO RGD:10686 6480464 Tadalafil inhibits the reaction [Thioacetamide results in decreased expression of GRIN2A protein] CTD PMID:31323263 tartrazine multiple interactions EXP 6480464 [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein, [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 tetrodotoxin multiple interactions ISO RGD:10686 6480464 Tetrodotoxin inhibits the reaction [ciguatoxin 3C results in decreased expression of GRIN2A protein] CTD PMID:25945544 thioacetamide decreases expression ISO RGD:10686 6480464 Thioacetamide results in decreased expression of GRIN2A protein CTD PMID:31323263 thioacetamide multiple interactions ISO RGD:10686 6480464 Tadalafil inhibits the reaction [Thioacetamide results in decreased expression of GRIN2A protein] CTD PMID:31323263 titanium dioxide decreases expression ISO RGD:10686 6480464 titanium dioxide results in decreased expression of GRIN2A mRNA, titanium dioxide results in decreased expression of GRIN2A protein CTD PMID:25411160 toluene increases expression EXP 6480464 Toluene results in increased expression of GRIN2A protein CTD PMID:15695158 toluene increases expression ISO RGD:10686 6480464 Toluene results in increased expression of GRIN2A mRNA CTD PMID:17870172 , PMID:20804784 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of GRIN2A mRNA CTD PMID:19591855 trichostatin A decreases expression ISO RGD:732269 6480464 trichostatin A results in decreased expression of GRIN2A mRNA CTD PMID:24935251 urethane multiple interactions ISO RGD:732269 6480464 Urethane inhibits the reaction [Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein]] CTD PMID:11812690 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GRIN2A protein CTD PMID:17675408 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of GRIN2A mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GRIN2A mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:732269 6480464 Valproic Acid results in increased expression of GRIN2A mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:732269 6480464 Valproic Acid affects the expression of GRIN2A mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:732269 6480464 Valproic Acid results in decreased expression of GRIN2A mRNA CTD PMID:24935251 venlafaxine hydrochloride affects expression EXP 6480464 Venlafaxine Hydrochloride affects the expression of GRIN2A mRNA CTD PMID:25423262 zinc atom decreases activity EXP 6480464 Zinc results in decreased activity of GRIN2A protein CTD PMID:16822975 zinc dichloride multiple interactions EXP 6480464 AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of GRIN2A protein], zinc chloride results in increased expression of and results in increased phosphorylation of GRIN2A protein CTD PMID:12211081 zinc(0) decreases activity EXP 6480464 Zinc results in decreased activity of GRIN2A protein CTD PMID:16822975
Biological Process action potential IMP 1642204 ; 1642207 RGD calcium ion transmembrane import into cytosol ISO RGD:732269 1624291 (PMID:26875626), (PMID:27839871) RGD PMID:26875626 , PMID:27839871 calcium ion transmembrane import into cytosol ISS UniProtKB:Q12879 1600115 GO_REF:0000024 UniProt GO_REF:0000024 calcium ion transmembrane import into cytosol IEA UniProtKB:Q12879 , ensembl:ENSP000003325491600115 GO_REF:0000107 Ensembl GO_REF:0000107 calcium ion transport ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:2384280 more ... calcium-mediated signaling IEA GO:0022849 1600115 GO_REF:0000108 GOC GO_REF:0000108 cellular response to amino acid stimulus IMP 2326036 glycine RGD cellular response to amyloid-beta NOT ISO RGD:732269 1624291 UniProtKB:Q05586 (PMID:21883149) RGD PMID:21883149 cellular response to dsRNA IEP 2325933 miR-132 RGD cellular response to growth factor stimulus IEP 2325933 BDNF RGD cellular response to lipid IEP 2325951 ganglioside GQ1b RGD cellular response to magnesium ion IEP 2326036 RGD cellular response to manganese ion IEP 2325970 RGD cellular response to zinc ion IMP 2326029 RGD cerebral cortex development IEP 2325985 RGD chemical synaptic transmission IMP 1358643 RGD chemical synaptic transmission ISO RGD:10686 1624291 MGI:MGI:1928506 (MGI:MGI:894616 , PMID:9147327) RGD MGI:MGI:894616 , PMID:9147327 dendritic spine organization IMP 11085451 PMID:26679993 UniProt detection of mechanical stimulus involved in sensory perception of pain NOT ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:3604261 , PMID:16190898) RGD MGI:MGI:3604261 , PMID:16190898 directional locomotion ISO RGD:10686 1624291 MGI:MGI:95822 (MGI:MGI:1928500 , PMID:8987814) RGD MGI:MGI:1928500 , PMID:8987814 directional locomotion IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 dopamine metabolic process ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:2384280 , PMID:11160454) RGD MGI:MGI:2384280 , PMID:11160454 dopamine metabolic process IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 excitatory postsynaptic potential IMP 2325882 RGD excitatory postsynaptic potential IBA MGI:MGI:95820 more ... 13792537 PMID:21873635 GO_Central excitatory postsynaptic potential IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 excitatory postsynaptic potential ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:1928500 more ... hippocampus development IEP 2325978 RGD ionotropic glutamate receptor signaling pathway IDA 1642190 RGD ionotropic glutamate receptor signaling pathway IEA GO:0022849 1600115 GO_REF:0000108 GOC GO_REF:0000108 ionotropic glutamate receptor signaling pathway IEA GO:0004972 1600115 GO_REF:0000108 GOC GO_REF:0000108 ionotropic glutamate receptor signaling pathway IEA GO:0004970 1600115 GO_REF:0000108 GOC GO_REF:0000108 learning ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:2384280 more ... learning or memory ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:1277016 more ... RGD MGI:MGI:1277016 more ... locomotion ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:2384280 more ... RGD MGI:MGI:2384280 more ... long-term synaptic potentiation IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 long-term synaptic potentiation ISO RGD:10686 1624291 MGI:MGI:109137 more ... RGD MGI:MGI:3770075 more ... long-term synaptic potentiation IBA MGI:MGI:95820 more ... 13792537 PMID:21873635 GO_Central memory ISO RGD:10686 1624291 MGI:MGI:1928287 (MGI:MGI:1195436 , PMID:9458051) RGD MGI:MGI:1195436 , PMID:9458051 memory IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 memory IDA 8553269 PMID:16157280 UniProt modulation of chemical synaptic transmission ISO RGD:10686 1624291 (MGI:MGI:3687911, PMID:12427824) RGD MGI:MGI:3687911 , PMID:12427824 negative regulation of protein catabolic process ISO RGD:10686 1624291 MGI:MGI:95822 (MGI:MGI:3054180 , PMID:15317856) RGD MGI:MGI:3054180 , PMID:15317856 negative regulation of protein catabolic process IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 neurogenesis ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:3607839 , PMID:12941447) RGD MGI:MGI:3607839 , PMID:12941447 neurogenesis IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of apoptotic process ISO RGD:10686 1624291 MGI:MGI:1096575 more ... RGD MGI:MGI:3757796 , PMID:17803966 positive regulation of apoptotic process IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell death IDA 2325881 RGD positive regulation of excitatory postsynaptic potential IDA 8554754 PMID:12930820 BHF-UCL protein localization to postsynaptic membrane ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:3054180 , PMID:15317856 protein localization to postsynaptic membrane IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of long-term neuronal synaptic plasticity IMP 1642204 ; 1642207 RGD regulation of membrane potential ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:1277016 more ... RGD MGI:MGI:1277016 more ... regulation of NMDA receptor activity IMP 11085451 PMID:26679993 UniProt regulation of postsynaptic membrane potential ISO RGD:10686 1624291 (MGI:MGI:3689798, PMID:16157280) RGD MGI:MGI:3689798 , PMID:16157280 regulation of presynaptic membrane potential IEA GO:0099507 1600115 GO_REF:0000108 GOC GO_REF:0000108 regulation of synaptic plasticity ISO RGD:10686 1624291 (MGI:MGI:3687911, PMID:12427824) RGD MGI:MGI:3687911 , PMID:12427824 response to amine IEP 2325941 ketamine RGD response to ammonium ion IEP 2325930 RGD response to amphetamine ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:3656418 , PMID:15731593) RGD MGI:MGI:3656418 , PMID:15731593 response to amphetamine IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to calcium ion IEP 2325954 RGD response to carbohydrate IEP 2325956 formalin RGD response to cocaine IEP 2326006 RGD response to drug IEP 2325865 antidepressant fluoxetine RGD response to drug IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to drug IEP 2325930 allopurinol RGD response to drug ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:3041713 , PMID:14750973) RGD MGI:MGI:3041713 , PMID:14750973 response to ethanol IEP 2325958 RGD response to ethanol IMP 13432288 PMID:27876530 ARUK-UCL response to ethanol IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to ethanol IEA UniProtKB:Q12879 , ensembl:ENSP000003325491600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to ethanol ISO RGD:732269 1624291 (PMID:18445116) RGD PMID:18445116 response to ethanol ISO RGD:10686 1624291 MGI:MGI:1928287 (MGI:MGI:2677534 , PMID:11530236) RGD MGI:MGI:2677534 , PMID:11530236 response to fungicide IEP 2325972 tributyltin RGD response to light stimulus IEP 2325946 RGD response to manganese ion IEP 2325871 RGD response to methylmercury IEP 2325985 RGD response to organic cyclic compound IEP 2326006 ouabain RGD response to other organism IEP 2325976 isolation rearing RGD response to wounding ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:1201242 more ... response to wounding IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 rhythmic process IDA 1642190 RGD sensory perception of pain IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 sensory perception of pain ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:1353324 more ... RGD MGI:MGI:1353324 more ... serotonin metabolic process ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:2384280 , PMID:11160454) RGD MGI:MGI:2384280 , PMID:11160454 serotonin metabolic process IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 sleep ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:3629276 , PMID:12754515) RGD MGI:MGI:3629276 , PMID:12754515 sleep IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 spinal cord development IEP 2325980 RGD startle response NOT ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:1339865 , PMID:9718984) RGD MGI:MGI:1339865 , PMID:9718984 startle response IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 startle response ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:3040117 more ... visual learning ISO RGD:10686 1624291 MGI:MGI:1928285 (MGI:MGI:70176 , PMID:7816096) RGD MGI:MGI:70176 , PMID:7816096 visual learning IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component cell surface IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell surface ISO RGD:10686 1624291 (MGI:MGI:3765383 more ... RGD MGI:MGI:3765383 more ... cytoplasmic vesicle membrane IEA UniProtKB-SubCell:SL-0089 1600115 GO_REF:0000044 UniProt GO_REF:0000044 dendritic spine IDA 8554784 PMID:16221859 MGI dendritic spine IDA 11085451 PMID:26679993 UniProt endoplasmic reticulum ISO RGD:10686 1624291 (MGI:MGI:3654399, PMID:16814779) RGD MGI:MGI:3654399 , PMID:16814779 endoplasmic reticulum IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 glutamatergic synapse IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 glutamatergic synapse ISO RGD:10686 1624291 (MGI:MGI:4358803, PMID:19726645) RGD MGI:MGI:4358803 , PMID:19726645 glutamatergic synapse IMP 2325961 PMID:19666514 SynGO glutamatergic synapse IMP 13792531 PMID:12160751 SynGO glutamatergic synapse IDA 13792531 PMID:12160751 SynGO glutamatergic synapse IDA 2325961 PMID:19666514 SynGO glutamatergic synapse EXP 2325961 PMID:19666514 SynGO integral component of plasma membrane ISO RGD:732269 1624291 (PMID:26875626) RGD PMID:26875626 integral component of plasma membrane IDA 13432313 PMID:28384476 UniProt integral component of plasma membrane IDA 13432339 PMID:23625947 UniProt integral component of postsynaptic density membrane IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 integral component of postsynaptic density membrane ISO RGD:10686 1624291 (MGI:MGI:4358803, PMID:19726645) RGD MGI:MGI:4358803 , PMID:19726645 integral component of presynaptic membrane IDA 2325961 PMID:19666514 SynGO membrane ISO RGD:10686 1624291 (MGI:MGI:4941854 more ... RGD MGI:MGI:4941854 more ... neuron projection IDA 8554028 PMID:12738960 UniProt neuron projection ISO RGD:10686 1624291 (MGI:MGI:5013997 more ... RGD MGI:MGI:5013997 more ... neuron projection IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 NMDA selective glutamate receptor complex IDA 1642190 ; 7241301 RGD NMDA selective glutamate receptor complex IBA MGI:MGI:95820 more ... 13792537 PMID:21873635 GO_Central NMDA selective glutamate receptor complex IDA 13432313 PMID:28384476 UniProt NMDA selective glutamate receptor complex IDA 13432339 PMID:23625947 UniProt NMDA selective glutamate receptor complex IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 NMDA selective glutamate receptor complex ISO RGD:10686 1624291 PR:P35438 more ... RGD MGI:MGI:68623 more ... NMDA selective glutamate receptor complex IEA UniProtKB:Q12879 , ensembl:ENSP000003325491600115 GO_REF:0000107 Ensembl GO_REF:0000107 NMDA selective glutamate receptor complex IDA 8553561 PMID:8702950 UniProt NMDA selective glutamate receptor complex ISO RGD:732269 1624291 (PMID:10480938), (PMID:26875626) RGD PMID:10480938 , PMID:26875626 parallel fiber to Purkinje cell synapse IDA 2325961 PMID:19666514 SynGO plasma membrane TAS 1600115 Reactome:R-RNO-6794342 Reactome Reactome:R-RNO-6794342 plasma membrane TAS 1600115 Reactome:R-RNO-9612145 Reactome Reactome:R-RNO-9612145 plasma membrane IBA FB:FBgn0004620 more ... 13792537 PMID:21873635 GO_Central plasma membrane TAS 1600115 Reactome:R-RNO-9614351 Reactome Reactome:R-RNO-9614351 plasma membrane TAS 1600115 Reactome:R-RNO-9614350 Reactome Reactome:R-RNO-9614350 plasma membrane TAS 1600115 Reactome:R-RNO-9614228 Reactome Reactome:R-RNO-9614228 plasma membrane ISO RGD:732269 1624291 (PMID:27839871) RGD PMID:27839871 plasma membrane TAS 1600115 Reactome:R-RNO-6794359 Reactome Reactome:R-RNO-6794359 postsynaptic density IDA 2326005 RGD postsynaptic density ISO RGD:10686 1624291 (MGI:MGI:5286805 more ... RGD MGI:MGI:5286805 more ... postsynaptic density IDA 13432267 PMID:9509416 UniProt postsynaptic density membrane ISO RGD:10686 1624291 (MGI:MGI:4358803, PMID:19726645) RGD MGI:MGI:4358803 , PMID:19726645 postsynaptic density membrane IBA MGI:MGI:95820 more ... 13792537 PMID:21873635 GO_Central postsynaptic membrane ISO RGD:10686 1624291 (MGI:MGI:2447007 more ... RGD MGI:MGI:2447007 more ... postsynaptic membrane IDA 11085451 PMID:26679993 UniProt presynaptic membrane IDA 8553269 PMID:16157280 UniProt presynaptic membrane IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 presynaptic membrane ISO RGD:10686 1624291 (MGI:MGI:3689798, PMID:16157280) RGD MGI:MGI:3689798 , PMID:16157280 synapse ISO RGD:10686 1624291 (MGI:MGI:2680876 more ... RGD MGI:MGI:2680876 more ... synapse TAS 8553534 PMID:16407536 UniProt synaptic membrane ISO RGD:10686 1624291 (MGI:MGI:5703671, PMID:26609151) RGD MGI:MGI:5703671 , PMID:26609151 synaptic vesicle ISO RGD:10686 1624291 (MGI:MGI:4454727, PMID:20418887) RGD MGI:MGI:4454727 , PMID:20418887 synaptic vesicle IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 terminal bouton IDA 2325961 RGD Molecular Function ATPase binding IPI RGD:2176 2326002 RGD calcium channel activity contributes_to ISO RGD:10686 1624291 MGI:MGI:95819 (MGI:MGI:65947 , PMID:1374164) RGD MGI:MGI:65947 , PMID:1374164 calcium channel activity ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:2384280 more ... cation channel activity contributes_to IDA 1581396 PMID:12408866 UniProt cation channel activity ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:3610666 more ... cell adhesion molecule binding IPI RGD:68423 1642315 RGD cell adhesion molecule binding IPI RGD:68424 1642315 RGD cell adhesion molecule binding IPI RGD:2505 1642315 RGD extracellularly glutamate-gated ion channel activity contributes_to IMP 8554578 PMID:9425000 UniProt glutamate binding IDA 7241434 RGD glutamate binding IMP 8554578 PMID:9425000 UniProt glutamate receptor binding IPI RGD:2736 2326007 RGD glutamate-gated calcium ion channel activity IEA UniProtKB:Q12879 , ensembl:ENSP000003325491600115 GO_REF:0000107 Ensembl GO_REF:0000107 glutamate-gated calcium ion channel activity ISS UniProtKB:Q12879 1600115 GO_REF:0000024 UniProt GO_REF:0000024 glutamate-gated calcium ion channel activity ISO RGD:732269 1624291 (PMID:26875626), (PMID:27839871) RGD PMID:26875626 , PMID:27839871 ionotropic glutamate receptor activity IDA 1642190 RGD ionotropic glutamate receptor activity contributes_to IMP 2326036 RGD ionotropic glutamate receptor activity IMP 2326029 RGD ligand-gated ion channel activity IBA FB:FBgn0004619 more ... 13792537 PMID:21873635 GO_Central ligand-gated ion channel activity involved in regulation of presynaptic membrane potential EXP 2325961 PMID:19666514 SynGO ligand-gated ion channel activity involved in regulation of presynaptic membrane potential IMP 2325961 PMID:19666514 SynGO ligand-gated ion channel activity involved in regulation of presynaptic membrane potential IDA 2325961 PMID:19666514 SynGO neurotransmitter binding IDA 1642190 RGD NMDA glutamate receptor activity IDA 1642190 ; 7241434 ; 728651 RGD NMDA glutamate receptor activity IDA 13432313 PMID:28384476 UniProt NMDA glutamate receptor activity IMP 13432339 PMID:23625947 UniProt NMDA glutamate receptor activity IEA UniProtKB:P35436 , ensembl:ENSMUSP000001429001600115 GO_REF:0000107 Ensembl GO_REF:0000107 NMDA glutamate receptor activity ISO RGD:10686 1624291 MGI:MGI:1928285 more ... RGD MGI:MGI:1201242 more ... NMDA glutamate receptor activity contributes_to ISO RGD:10686 1624291 MGI:MGI:95819 more ... RGD MGI:MGI:65947 more ... NMDA glutamate receptor activity IMP 1642380 RGD protein binding IPI RGD:70991 2326007 RGD protein binding ISO RGD:732269 1624291 UniProtKB:P31016 more ... RGD PMID:11937501 more ... protein binding ISO RGD:10686 1624291 PR:P35438 more ... RGD MGI:MGI:1270002 more ... protein binding IPI UniProtKB:Q8R4I7 13432354 PMID:19243221 IntAct protein binding IPI UniProtKB:P05480 8554759 PMID:21199370 IntAct protein binding IPI UniProtKB:P47709 11085451 PMID:26679993 UniProt protein binding IPI UniProtKB:P31016 11085451 PMID:26679993 UniProt protein binding IPI UniProtKB:Q62936 8553561 PMID:8702950 UniProt protein binding IPI UniProtKB:P31016 8554595 PMID:8601796 IntAct protein binding IPI UniProtKB:P31016 8554530 PMID:7569905 IntAct protein binding IPI UniProtKB:P31016 8554042 PMID:10336672 IntAct protein binding IPI UniProtKB:P18901 1581396 PMID:12408866 UniProt protein binding IPI RGD:70993 2326007 RGD protein kinase binding IPI RGD:620795 2325245 RGD protein-containing complex binding IDA 7241301 heterotetramerization RGD protein-containing complex binding IDA 7241533 heterodimerization RGD protein-containing complex binding IPI RGD:620795 , RGD:68424 2325012 RGD protein-containing complex binding IPI RGD:620795 more ... 2325253 RGD scaffold protein binding IPI UniProtKB:P31016 8554370 PMID:20847060 BHF-UCL signaling receptor activity IBA FB:FBgn0004619 more ... 13792537 PMID:21873635 GO_Central signaling receptor binding IPI RGD:2518 1581396 RGD transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential IDA 13792531 PMID:12160751 SynGO transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential IMP 13792531 PMID:12160751 SynGO voltage-gated cation channel activity IMP 1642380 RGD zinc ion binding IDA 2326029 RGD zinc ion binding ISS UniProtKB:Q00960 1600115 GO_REF:0000024 UniProt GO_REF:0000024
Gene-Chemical Interaction Annotations
